Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,248 across all filing types
Latest filing 2019-04-11 Major Shareholding Noti…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It provides detailed information about the aggregate shareholding and voting rights of the Promoter(s)/Promoter Group and Persons Acting in Concert as of March 31, 2019. The content includes names of promoters, shareholding percentages, and changes in promoter group composition. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about shareholding. Therefore, the correct classification is MRQ with high confidence.
2019-04-11 English
With reference to the circulars issued by BSE vide Circular no. LIST/COMP/01/2019-20 and NSE vide Circular no. NSE/CML/2019/11 dated April 2, 2019 pertaining to clarification regarding ....
Regulatory Filings Classification · 95% confidence The document is a notification titled 'Intimation of Closure of Trading Window' referencing SEBI regulations and circulars from BSE and NSE. It informs about the closure of the trading window for designated persons until 48 hours after the announcement of financial results for the quarter and financial year ended March 31, 2019. The document is short (3604 characters) and serves as an announcement related to insider trading compliance rather than containing any financial data or report. It does not contain financial statements or detailed financial analysis. Therefore, it is not an Annual Report, Interim Report, Earnings Release, or any detailed financial filing. It is a regulatory announcement related to trading restrictions and compliance with insider trading regulations. Hence, the appropriate classification is Regulatory Filings (RNS).
2019-04-04 English
Trading Window
Regulatory Filings Classification · 90% confidence The document text is extremely short (386 characters) and consists mainly of addresses and stock exchange listing department references. There is no substantive financial data, report content, or detailed information. It appears to be a brief communication or notice related to stock exchange listing, without any report or financial statements attached. Given the brevity and nature, it does not qualify as a full report or detailed filing. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2019-04-04 English
Reply to Clarification Sought
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding clarifications on a previous announcement related to Bliss GVS Pharma. It discusses details about an Employee Stock Option Plan (ESOP) including the number of options, vesting schedule, exercise price, and other terms. The content is focused on explaining and clarifying terms of a stock option plan rather than reporting financial results or announcing a new report. It is not an annual or quarterly report, earnings release, or audit report. It is also not a proxy solicitation or voting results announcement. The document is a regulatory communication clarifying a prior announcement about stock options, which fits best under Regulatory Filings (RNS) as it does not constitute a full financial report or a direct capital/financing update but is a regulatory disclosure related to stock options.
2019-03-26 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Registrar and Transfer Agent of Company M/s. Universal ....
Regulatory Filings Classification · 95% confidence The document is an intimation regarding the loss of share certificates and the issuance of duplicate share certificates under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It lists shareholders who have requested duplicate certificates due to loss of original certificates. This is a regulatory announcement related to share certificate management and does not contain financial data, management discussion, or report content. It is not a financial report, earnings release, or management report. It is also not a voting result, capital change, or director dealing. The document is a regulatory filing informing the stock exchange and public about share certificate status changes as required by SEBI regulations. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-03-20 English
Pursuant to the provision of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of the newspaper advertisement ....
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a newspaper advertisement and official communication confirming the dispatch of a Postal Ballot Notice and Form by Bliss GVS Pharma Limited. It references the Companies Act, SEBI Listing Obligations, and details the process and timeline for postal ballot voting including e-voting. It does not contain financial statements, audit information, or management discussion of financial results. Instead, it is an announcement related to shareholder voting procedures and the dispatch of voting materials. The document is lengthy but primarily serves as a notice and confirmation of dispatch rather than the actual voting results or detailed meeting materials. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to shareholder voting processes and notices.
2019-03-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.